miR-150 inhibitor ameliorates adriamycin-induced focal segmental glomerulosclerosis.

Qi, Huimeng

miR-150 inhibitor ameliorates adriamycin-induced focal segmental glomerulosclerosis. [electronic resource] - Biochemical and biophysical research communications 02 2020 - 618-625 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1090-2104

10.1016/j.bbrc.2019.11.096 doi


Animals
Doxorubicin--adverse effects
Fibrosis
Genetic Therapy
Glomerulosclerosis, Focal Segmental--chemically induced
Humans
Kidney--metabolism
Mice
Mice, Inbred BALB C
MicroRNAs--antagonists & inhibitors
Oligonucleotides--therapeutic use